Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

The FDA grants orphan drug status for Avant's lead complement inhibitor

March 17, 2000

Novel features of H-345/52 indicate promising activity in tachyarrhythmia

March 16, 2000

Continued treatment with Enbrel safe and effective in chronic heart failure

March 16, 2000

New use for teprenone in myocardial preconditioning? Evidence presented at ACC meeting

March 16, 2000

CytRx to continue Flocor development as treatment for sickle cell disease

March 16, 2000

ACC news: preliminary clinical results presented for Chiron's rFGF-2 angiogenesis therapy

March 15, 2000

Baxter exercises option in cardiovascular collaboration with Sangamo

March 15, 2000

New treatment options for restenosis a hot topic at ACC

March 14, 2000

Exochelin has potential in restenosis, according to data presented to the ACC

March 14, 2000

Integrin receptor blockade assessed at DuPont for angiogenesis-mediated disorders

March 14, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...